Donepezil for the treatment of agitation in Alzheimer's disease.

Donepezil for the treatment of agitation in Alzheimer's disease.

BACKGROUND: Agitation is a common and distressing symptom in patients with Alzheimer's disease. Cholinesterase inhibitors improve cognitive outcomes in such patients, but the benefits of these drugs for behavioral disturbances are unclear. METHODS: We randomly assigned 272 patients with Alzheim...

Full description

Bibliographic Details
Main Authors:	Howard, R, Juszczak, E, Ballard, C, Bentham, P, Brown, R, Bullock, R, Burns, A, Holmes, C, Jacoby, R, Johnson, T, Knapp, M, Lindesay, J, O'Brien, J, Wilcock, G, Katona, C, Jones, R, DeCesare, J, Rodger, M
Format:	Journal article
Language:	English
Published:	Massachusetts Medical Society 2007

Similar Items

Donepezil and memantine for moderate-to-severe Alzheimer's disease
by: Howard, R, et al.
Published: (2012)

Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial).
by: Ballard, C, et al.
Published: (2009)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
by: Jones, R, et al.
Published: (2009)

Donepezil for dementia due to Alzheimer's disease
by: Birks, J, et al.
Published: (2018)

A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
by: Wilcock, G, et al.
Published: (2003)

Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease Reply
by: Howard, R, et al.
Published: (2012)

Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
by: Wilcock, G, et al.
Published: (2008)

Peran donepezil dalam terapi penyakit alzheimer
by: Perpustakaan UGM, i-lib
Published: (1999)

Galantamine vs donepezil in the treatment of Alzheimer's disease.
by: Goldlist, B, et al.
Published: (2003)

Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study
by: Griffanti, L, et al.
Published: (2016)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
by: Pratt, R, et al.
Published: (2001)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
by: Perdomo, C, et al.
Published: (2003)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease
by: Wilcock, G, et al.
Published: (2001)

Donepezil for vascular cognitive impairment
by: Malouf, R, et al.
Published: (2004)

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.
by: Whitehead, A, et al.
Published: (2004)

A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: An intent-to-treat analysis
by: Wilcock, G, et al.
Published: (2003)

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
by: Ballard, C, et al.
Published: (2005)

Determining the minimum clinically important differences for outcomes in the DOMINO trial.
by: Howard, R, et al.
Published: (2011)

Issues in drug treatment for Alzheimer's disease.
by: Mcshane, R, et al.
Published: (1997)

Agitation-free multiphoton microscopy of oblique planes.
by: Smith, C, et al.
Published: (2011)

Treatment benefits of memantine in moderately severe to severe Alzheimer's disease patients with behavioural symptoms
by: Wilcock, G, et al.
Published: (2006)

Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.
by: Chalmers, K, et al.
Published: (2009)

Mixing of liquids by mechanical agitation/
by: Ulbrecht, Jaromir J., et al.
Published: (1985)

Early- and subsequent- response of cognitive functioning in Alzheimer's disease: Individual-participant data from five pivotal randomized clinical trials of donepezil
by: Levine, SZ, et al.
Published: (2022)

Personalized prediction of Alzheimer's disease and its treatment effects by donepezil: an individual participant data meta-analysis of eight randomized controlled trials
by: Yoshida, K, et al.
Published: (2022)

Psychotic symptoms in dementia and the rate of cognitive decline.
by: Ballard, C, et al.
Published: (1997)

Bright light therapy for agitation in dementia: a randomized controlled trial.
by: Burns, A, et al.
Published: (2009)

A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome.
by: Ballard, C, et al.
Published: (2004)

Interventions in Alzheimer's disease.
by: Bucks, R, et al.
Published: (2002)

Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
by: Ballard, C, et al.
Published: (1996)

Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.
by: Morar, C, et al.
Published: (1983)

Power requirement in agitation systems
by: Stern, William Rogers
Published: (2019)

Cost estimation for turbine agitators /
by: 287719 Meyer, William S, et al.

Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.
by: Forsyth, DR, et al.
Published: (1989)

Pathologic diagnosis of Alzheimer's.
by: Köster, R, et al.
Published: (1989)

Issues in drug treatment for Alzheimer's disease (multiple letters) [14]
by: McShane, R, et al.
Published: (1997)

Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study.
by: Hope, T, et al.
Published: (1999)

Ultrafast chronoamperometry of single impact events in acoustically agitated solid particulate suspensions.
by: Clegg, A, et al.
Published: (2006)

Visual search in Alzheimer's disease
by: Tales, A, et al.
Published: (2000)

Velnacrine for Alzheimer's disease.
by: Birks, J, et al.
Published: (2004)